Bank of New York Mellon
HRMY icon

Bank of New York Mellon’s Harmony Biosciences HRMY Stock Holding History

Bank of New York Mellon’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.94M Buy
272,926
+8,515
+3% +$269K ﹤0.01% 2038
2026
Q1 		$7.41M Sell
264,411
-6
-0% -$197 ﹤0.01% 2087
2025
Q4 		$9.89M Sell
264,417
-269
-0.1% -$8.85K ﹤0.01% 1930
2025
Q3 		$7.29M Sell
264,686
-6,749
-2% -$232K ﹤0.01% 2111
2025
Q2 		$8.58M Buy
271,435
+9,197
+4% +$296K ﹤0.01% 1981
2025
Q1 		$8.7M Sell
262,238
-3,401
-1% -$122K ﹤0.01% 1919
2024
Q4 		$9.14M Buy
265,639
+32,272
+14% +$1.11M ﹤0.01% 1967
2024
Q3 		$9.33M Sell
233,367
-36,460
-14% -$1.28M ﹤0.01% 1974
2024
Q2 		$8.14M Sell
269,827
-18,820
-7% -$566K ﹤0.01% 2072
2024
Q1 		$9.69M Sell
288,647
-14,842
-5% -$476K ﹤0.01% 1972
2023
Q4 		$9.8M Buy
303,489
+39,094
+15% +$1.09M ﹤0.01% 2000
2023
Q3 		$8.66M Buy
264,395
+10,538
+4% +$366K ﹤0.01% 2028
2023
Q2 		$8.93M Sell
253,857
-6,713
-3% -$232K ﹤0.01% 2001
2023
Q1 		$8.51M Sell
260,570
-13,067
-5% -$595K ﹤0.01% 2008
2022
Q4 		$15.1M Buy
273,637
+4,235
+2% +$233K ﹤0.01% 1705
2022
Q3 		$11.9M Buy
269,402
+42,280
+19% +$2.06M ﹤0.01% 1803
2022
Q2 		$11.1M Buy
227,122
+9,818
+5% +$442K ﹤0.01% 1872
2022
Q1 		$10.6M Buy
217,304
+17,893
+9% +$730K ﹤0.01% 2041
2021
Q4 		$8.5M Buy
199,411
+130,858
+191% +$5.22M ﹤0.01% 2187
2021
Q3 		$2.63M Buy
68,553
+23,407
+52% +$754K ﹤0.01% 2838
2021
Q2 		$1.27M Buy
45,146
+32,069
+245% +$962K ﹤0.01% 3267
2021
Q1 		$432K Buy
13,077
+1,779
+16% +$62.4K ﹤0.01% 3762
2020
Q4 		$408K Buy
+11,298
New +$456K ﹤0.01% 3713

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon's HRMY Position: Q2 2026 in Review

Bank of New York Mellon increased its Harmony Biosciences (HRMY) stake by 3.2% in Q2 2026, buying an estimated $269K and bringing the position to 272,926 shares worth $9.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

Bank of New York Mellon first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $15.1M in Q4 2022. 142 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bank of New York Mellon held 272,926 shares of Harmony Biosciences worth $9.94M as of Q2 2026.
  • Bank of New York Mellon bought 8,515 Harmony Biosciences shares in Q2 2026, an estimated $269K.
  • Harmony Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2038 holding.
  • Bank of New York Mellon first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Bank of New York Mellon's Harmony Biosciences position peaked at $15.1M in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.